Browse everything: Tickers A–Z · Issuers · Comparisons · Tags
NMTC Stock — Neuroone Medical Technologies Corp
Neuroone Medical Technologies Corp (NMTC)
Updated October 16, 2026.
NMTC is a Stock. Total return is 56452.9% over the past 13.5 years, 55935.0 points ahead of SPY at 517.9%.
NeuroOne Medical Technologies Corporation develops medical devices for neurological conditions, offering solutions for continuous brain wave monitoring and treatments for epilepsy, movement disorders, and chronic pain through neuromodulation and drug delivery technologies. The company does not currently distribute dividends to shareholders. NeuroOne appeals to investors seeking exposure to the medical device sector rather than those focused on generating current income.
NMTC performance versus SPY
Price and return data through 2026-10-16.
Total return is 56452.9% over the past 13.5 years, 55935.0 points ahead of SPY at 517.9%. Over the past year its total return — price change plus distributions reinvested — is -81.4%. Its deepest 1-year drawdown was 83.7%.
| Window | Total return | CAGR |
|---|---|---|
| 1M | -31.8% | — |
| 3M | -59.4% | — |
| 6M | -79.0% | — |
| YTD | -78.9% | — |
| 1Y | -81.4% | — |
| 2Y CAGR | — | -58.50% |
| 3Y CAGR | — | -44.30% |
| 5Y CAGR | — | -44.30% |
| 10Y CAGR | — | 88.40% |
| Since inception (13.5 years) | 56452.9% | 59.70% |
NMTC key facts
- Asset type
- Stock
- Asset class
- Equity
- Inception date
- 08/01/2017
- Distribution frequency
- None
- Last close
- $0.96 (as of 2026-10-16)
- Market cap
- $8,754,281
- Average volume
- 94217.0
- Beta
- 0.761
- Payout ratio
- 0.0%
- EPS
- $-0.99
How Dividend Vision calculates yield and returns
Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.
Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology
Sources and review
Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.
Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.
NMTC risks and drawbacks
The deepest 1-year drawdown on record here is 83.7%.
Who may consider NMTC — and who may not
It is a weaker fit for investors who need monthly cash flow (NMTC does not currently distribute). This is educational context, not a recommendation to buy or sell.
More on NMTC
Frequently asked questions
Does NMTC pay monthly?
No. NMTC does not currently distribute.
When does NMTC pay a dividend?
NMTC does not currently distribute.
How has NMTC performed?
Total return is 56452.9% over the past 13.5 years, 55935.0 points ahead of SPY at 517.9%. Over the past year its total return — price change plus distributions reinvested — is -81.4%. Its deepest 1-year drawdown was 83.7%.
Tickers
Holdings as-of date unavailable.
| Ticker | Name | Weight |
|---|
See how this investment would fit into your portfolio.